Vitae Pharmaceuticals
Latest round
- Series D
Last raised
- Oct 2007
Total raised
- $109M
Investors
- 7
About Vitae Pharmaceuticals
operates as a clinical-stage biopharmaceutical company, developing small molecule drugs for the treatment of autoimmune disorders such as psoriasis and atopic dermatitis.
Who invested in Vitae Pharmaceuticals
7 investors across 6 rounds
See all investors in Vitae Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vitae Pharmaceuticals
Who invested in Vitae Pharmaceuticals?
Vitae Pharmaceuticals has 7 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vitae Pharmaceuticals raised?
Vitae Pharmaceuticals has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Vitae Pharmaceuticals last raise money?
Vitae Pharmaceuticals's most recent round on record is a Series D, in Oct 2007.
What does Vitae Pharmaceuticals do?
operates as a clinical-stage biopharmaceutical company, developing small molecule drugs for the treatment of autoimmune disorders such as psoriasis and atopic dermatitis.
Where is Vitae Pharmaceuticals headquartered?
Vitae Pharmaceuticals is headquartered in Fort Washington, US.
Which VCs invest in companies like Vitae Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vitae Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Vitae Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.